Anzahl der Einträge: 6.
2024
Welters, Marthe‐Lina,
Stadler, Serena,
Anastasopoulou, Vasiliki,
Bullinger, Lars,
Leisegang, Matthias,
Kammertöns, Thomas,
Welters, Carlotta und
Hansmann, Leo
(2024)
Oligonucleotide library screening for identification of virus‐specific T‐cell receptors.
European Journal of Immunology.
2021
Liebers, Nora,
Duell, Johannes,
Fitzgerald, Donnacha,
Kerkhoff, Andrea,
Noerenberg, Daniel,
Kaebisch, Eva,
Acker, Fabian,
Fuhrmann, Stephan,
Leng, Corinna,
Welslau, Manfred,
Chemnitz, Jens,
Middeke, Jan-Moritz,
Weber, Thomas,
Holtick, Udo,
Trappe, Ralf,
Pfannes, Roald,
Liersch, Ruediger,
Spoer, Christian,
Fuxius, Stefan,
Gebauer, Niklas,
Caillé, Léandra,
Geer, Thomas,
Koenecke, Christian,
Keller, Ulrich,
Claus, Rainer,
Mougiakakos, Dimitrios,
Mayer, Stephanie,
Huettmann, Andreas,
Pott, Christiane,
Trummer, Arne,
Wulf, Gerald,
Brunnberg, Uta,
Bullinger, Lars,
Hess, Georg,
Mueller-Tidow, Carsten,
Glass, Bertram,
Lenz, Georg,
Dreger, Peter und
Dietrich, Sascha
(2021)
Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas.
Blood Advances 5 (13), S. 2707-2716.
Volltext nicht vorhanden.
2019
Weller, Johannes ,
Tzaridis, Theophilos,
Mack, Frederic,
Steinbach, Joachim Peter,
Schlegel, Uwe,
Hau, Peter,
Krex, Dietmar,
Grauer, Oliver,
Goldbrunner, Roland,
Bähr, Oliver,
Uhl, Martin,
Seidel, Clemens,
Tabatabai, Ghazaleh ,
Brehmer, Stefanie,
Bullinger, Lars,
Galldiks, Norbert ,
Schaub, Christina,
Kebir, Sied,
Stummer, Walter,
Simon, Matthias,
Fimmers, Rolf,
Coch, Christoph,
Glas, Martin,
Herrlinger, Ulrich und
Schäfer, Niklas
(2019)
Health-related quality of life and neurocognitive functioning with lomustine–temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial.
The Lancet Oncology 20 (10), S. 1444-1453.
Volltext nicht vorhanden.
Herrlinger, Ulrich,
Tzaridis, Theophilos,
Mack, Frederic,
Steinbach, Joachim Peter,
Schlegel, Uwe,
Sabel, Michael,
Hau, Peter ,
Kortmann, Rolf-Dieter,
Krex, Dietmar,
Grauer, Oliver,
Goldbrunner, Roland,
Schnell, Oliver,
Bähr, Oliver,
Uhl, Martin,
Seidel, Clemens,
Tabatabai, Ghazaleh ,
Kowalski, Thomas,
Ringel, Florian,
Schmidt-Graf, Friederike,
Suchorska, Bogdana,
Brehmer, Stefanie,
Weyerbrock, Astrid,
Renovanz, Miriam,
Bullinger, Lars,
Galldiks, Norbert ,
Vajkoczy, Peter,
Misch, Martin,
Vatter, Hartmut,
Stuplich, Moritz,
Schäfer, Niklas,
Kebir, Sied,
Weller, Johannes ,
Schaub, Christina,
Stummer, Walter,
Tonn, Jörg-Christian,
Simon, Matthias,
Keil, Vera C.,
Nelles, Michael,
Urbach, Horst,
Coenen, Martin,
Wick, Wolfgang ,
Weller, Michael ,
Fimmers, Rolf,
Schmid, Matthias ,
Hattingen, Elke ,
Pietsch, Torsten,
Coch, Christoph und
Glas, Martin
(2019)
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial.
The Lancet 393 (10172), S. 678-688.
Volltext nicht vorhanden.
2012
Dolnik, Anna,
Engelmann, Julia C.,
Scharfenberger-Schmeer, Maren,
Mauch, Julian,
Kelkenberg-Schade, Sabine,
Haldemann, Berit,
Fries, Tamara,
Krönke, Jan,
Kühn, Michael W. M.,
Paschka, Peter,
Kayser, Sabine,
Wolf, Stephan,
Gaidzik, Verena I.,
Schlenk, Richard F.,
Rücker, Frank G.,
Döhner, Hartmut,
Lottaz, Claudio,
Döhner, Konstanze und
Bullinger, Lars
(2012)
Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicing.
Blood 120 (18), e83-e92.
Volltext nicht vorhanden.
2007
Bullinger, Lars,
Rücker, Frank G.,
Kurz, Stephan,
Du, Juan,
Scholl, Claudia,
Sander, Sandrine,
Corbacioglu, Andrea,
Lottaz, Claudio,
Krauter, Jürgen,
Fröhling, Stefan,
Ganser, Arnold,
Schlenk, Richard F.,
Döhner, Konstanze,
Pollack, Jonathan R. und
Döhner, Hartmut
(2007)
Gene-expression profiling identifies distinct subclasses of core binding factor acute myeloid leukemia.
Blood 110 (4), S. 1291-1300.
Volltext nicht vorhanden.
Diese Liste wurde erzeugt am Thu Apr 25 01:52:15 2024 CEST.